Hepatitis B vaccination

References

• World Health Organization. Hepatitis B. 2008. Available at: http://www.who.int/mediacentre/factsheets /fs204/en/ (last access 18 june 2014).
   Google Scholar
• World Health Organization, Regional Office for Europe. Hepatitis B and C infect one in fifty adults in European Region. Available at: http://www.euro.who.int/en/health-topics/communicable-diseases/ hepatitis/news/news/2013/06/hepatitis-b-and-c-infect-one-in-fifty-adults-in-european-region# (last access 18 june 2014).
   Google Scholar
• World Health Organization. WHO expanded programme on immunisation. Global Advisory Group. Wkly Epidemiol Rec1992; 3:11 - 6
   Google Scholar
• ZanettiAR, Van DammeP, ShouvalD. The global impact of vaccination against hepatitis B: a historical overview. Vaccine2008; 26:6266 - 73; http://dx.doi.org/10.1016/j.vaccine.2008.09.056; PMID: 18848855
   PubMed Web of Science ®Google Scholar
• Ganem D, Schneider RJ. Hepadnaviridae: the viruses and their replication. In: Knipe DM, et al., eds. Fields Virology, 4th ed. Philadelphia, Lippincott Williams & Wilkins, 2001:2923-69.
   Google Scholar
• SeegerC, MasonWS. Hepatitis B virus biology. Microbiol Mol Biol Rev2000; 64:51 - 68; http://dx.doi.org/10.1128/MMBR.64.1.51-68.2000; PMID: 10704474
   PubMed Web of Science ®Google Scholar
• DienstagJL. Hepatitis B virus infection. N Engl J Med2008; 359:1486 - 500; http://dx.doi.org/10.1056/NEJMra0801644; PMID: 18832247
   PubMed Web of Science ®Google Scholar
• RossnerMT. Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator. J Med Virol1992; 36:101 - 17; http://dx.doi.org/10.1002/jmv.1890360207; PMID: 1583465
   PubMedGoogle Scholar
• PrinceAM, IkramH, HoppTP. Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc Natl Acad Sci U S A1982; 79:579 - 82; http://dx.doi.org/10.1073/pnas.79.2.579; PMID: 6176997
   PubMedGoogle Scholar
• NorderH, CouroucéAM, CoursagetP, EchevarriaJM, LeeSD, MushahwarIK, RobertsonBH, LocarniniS, MagniusLO. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology2004; 47:289 - 309; http://dx.doi.org/10.1159/000080872; PMID: 15564741
   PubMed Web of Science ®Google Scholar
• ErhardtA, BlondinD, HauckK, SagirA, KohnleT, HeintgesT, HäussingerD. Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut2005; 54:1009 - 13; http://dx.doi.org/10.1136/gut.2004.060327; PMID: 15951551
   PubMed Web of Science ®Google Scholar
• SchaeferS. Hepatitis B virus: significance of genotypes. J Viral Hepat2005; 12:111 - 24; http://dx.doi.org/10.1111/j.1365-2893.2005.00584.x; PMID: 15720525
   PubMedGoogle Scholar
• LiawYF, ChuCM. Hepatitis B virus infection. Lancet2009; 373:582 - 92; http://dx.doi.org/10.1016/S0140-6736(09)60207-5; PMID: 19217993
   PubMed Web of Science ®Google Scholar
• PujolFH, NavasMC, HainautP, CheminI. Worldwide genetic diversity of HBV genotypes and risk of hepatocellular carcinoma. Cancer Lett2009; 286:80 - 8; http://dx.doi.org/10.1016/j.canlet.2009.07.013; PMID: 19683385
   PubMedGoogle Scholar
• GuirgisBS, AbbasRO, AzzazyHM. Hepatitis B virus genotyping: current methods and clinical implications. Int J Infect Dis2010; 14:e941 - 53; http://dx.doi.org/10.1016/j.ijid.2010.03.020; PMID: 20674432
   PubMed Web of Science ®Google Scholar
• CarmanWF, KorulaJ, WallaceL, MacPheeR, MimmsL, DeckerR. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet1995; 345:1406 - 7; http://dx.doi.org/10.1016/S0140-6736(95)92599-6; PMID: 7539089
   PubMedGoogle Scholar
• MimmsL. Hepatitis B virus escape mutants: “pushing the envelope” of chronic hepatitis B virus infection. Hepatology1995; 21:884 - 7; PMID: 7875688
   PubMed Web of Science ®Google Scholar
• JongeriusJM, WesterM, CuypersHT, van OostendorpWR, LeliePN, van der PoelCL, van LeeuwenEF. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion1998; 38:56 - 9; http://dx.doi.org/10.1046/j.1537-2995.1998.38198141499.x; PMID: 9482395
   PubMed Web of Science ®Google Scholar
• ColemanPF, ChenYC, MushahwarIK. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol1999; 59:19 - 24; http://dx.doi.org/10.1002/(SICI)1096-9071(199909)59:1<19::AID-JMV4>3.0.CO;2-B; PMID: 10440803
   PubMedGoogle Scholar
• ZanettiAR, TanziE, ManzilloG, MaioG, SbregliaC, CaporasoN, ThomasH, ZuckermanAJ. Hepatitis B variant in Europe. Lancet1988; 2:1132 - 3; http://dx.doi.org/10.1016/S0140-6736(88)90541-7; PMID: 2460710
   PubMed Web of Science ®Google Scholar
• CarmanWF, ZanettiAR, KarayiannisP, WatersJ, ManzilloG, TanziE, ZuckermanAJ, ThomasHC. Vaccine-induced escape mutant of hepatitis B virus. Lancet1990; 336:325 - 9; http://dx.doi.org/10.1016/0140-6736(90)91874-A; PMID: 1697396
   PubMed Web of Science ®Google Scholar
• OgataN, ZanettiAR, YuM, MillerRH, PurcellRH. Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. J Infect Dis1997; 175:511 - 23; http://dx.doi.org/10.1093/infdis/175.3.511; PMID: 9041321
   PubMed Web of Science ®Google Scholar
• HsuHY, ChangMH, NiYH, LinHH, WangSM, ChenDS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology1997; 26:786 - 91; http://dx.doi.org/10.1002/hep.510260336; PMID: 9303514
   PubMed Web of Science ®Google Scholar
• Carman W, Thomas HC, Zuckerman AJ, et al. Molecular variants of hepatitis B virus. In: Zuckerman A, Thomas HC ed. Viral Hepatitis. 2nd ed. London, Churchill Livingstone, 1998: 141-72.
   Google Scholar
• ZuckermanAJ. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet2000; 355:1382 - 4; http://dx.doi.org/10.1016/S0140-6736(00)02132-2; PMID: 10791517
   PubMed Web of Science ®Google Scholar
• HsuHY, ChangMH, NiYH, ChenHL. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut2004; 53:1499 - 503; http://dx.doi.org/10.1136/gut.2003.034223; PMID: 15361503
   PubMed Web of Science ®Google Scholar
• Protzer-KnolleU, NaumannU, BartenschlagerR, BergT, HopfU, Meyer zum BüschenfeldeKH, NeuhausP, GerkenG. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology1998; 27:254 - 63; http://dx.doi.org/10.1002/hep.510270138; PMID: 9425945
   PubMed Web of Science ®Google Scholar
• NainanOV, KhristovaML, ByunK, XiaG, TaylorPE, StevensCE, MargolisHS. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J Med Virol2002; 68:319 - 27; http://dx.doi.org/10.1002/jmv.10206; PMID: 12226817
   PubMed Web of Science ®Google Scholar
• HsuHY, ChangMH, NiYH, ChiangCL, ChenHL, WuJF, ChenPJ. No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. J Infect Dis2010; 201:1192 - 200; http://dx.doi.org/10.1086/651378; PMID: 20210630
   PubMed Web of Science ®Google Scholar
• BianT, YanH, ShenL, WangF, ZhangS, CaoY, ZhangS, ZhangY, BiS. Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China. J Virol2013; 87:12196 - 206; http://dx.doi.org/10.1128/JVI.02127-13; PMID: 24006443
   PubMed Web of Science ®Google Scholar
• BianT, YanH, ShenL, WangF, ZhangS, CaoY, et al. Universal hepatitis B vaccination in China boosts breakthrough mutant viruses. Microbe2013; 8:393 - 4
   Google Scholar
• JilgW, NorderH, KaneM, Van DammeP, VorstersA, Viral Hepatitis Prevention Board. Reduced prevalence of HBsAg variants following a successful immunization program in China. J Virol2014; 88:4605 - 6; http://dx.doi.org/10.1128/JVI.03654-13; PMID: 24672049
   PubMedGoogle Scholar
• LocarniniS, ShouvalD. Commonly found variations/mutations in the HBsAg of hepatitis B virus in the context of effective immunization programs: questionable clinical and public health significance. J Virol2014; 88:6532; http://dx.doi.org/10.1128/JVI.00234-14; PMID: 24803487
   PubMedGoogle Scholar
• European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol2012; 57:167 - 85; PMID: 22436845
   PubMed Web of Science ®Google Scholar
• ZoulimF, LocarniniS. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology2009; 137:1593 - 608, e1-2; http://dx.doi.org/10.1053/j.gastro.2009.08.063; PMID: 19737565
   PubMed Web of Science ®Google Scholar
• GishR, JiaJD, LocarniniS, ZoulimF. Selection of chronic hepatitis B therapy with high barrier to resistance. Lancet Infect Dis2012; 12:341 - 53; http://dx.doi.org/10.1016/S1473-3099(11)70314-0; PMID: 22326017
   PubMed Web of Science ®Google Scholar
• PollicinoT, CacciolaI, SaffiotiF, RaimondoG.. Hepatitis B Virus PreS/S Gene Variants: Pathobiology and Clinical Implications. J Hepatol2014; 61:408 - 17; http://dx.doi.org/10.1016/j.jhep.2014.04.041; PMID: 24801416
   PubMed Web of Science ®Google Scholar
• NiYH, ChangMH, WuJF, HsuHY, ChenHL, ChenDS. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol2012; 57:730 - 5; http://dx.doi.org/10.1016/j.jhep.2012.05.021; PMID: 22668640
   PubMed Web of Science ®Google Scholar
• ChangMH, YouSL, ChenCJ, LiuCJ, LeeCM, LinSM, ChuHC, WuTC, YangSS, KuoHS, et al, Taiwan Hepatoma Study Group. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst2009; 101:1348 - 55; http://dx.doi.org/10.1093/jnci/djp288; PMID: 19759364
   PubMed Web of Science ®Google Scholar
• SEIEVA. Sistema Epidemiolgico Integrato dell’Epatite Virale Acuta. Istituto Superiore di Sanità, Roma. Available at http://www.iss.it/binary/seie/cont/Tassi_EpatiteB_2012.pdf (last access: 18 june 2014).
   Google Scholar
• Da VillaG, RomanòL, SepeA, IorioR, ParibelloN, ZappaA, ZanettiAR. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine2007; 25:3133 - 6; http://dx.doi.org/10.1016/j.vaccine.2007.01.044; PMID: 17280750
   PubMed Web of Science ®Google Scholar